Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: An estimated 5.6 million individuals in the U.S. experience limb loss and absence, but national estimates exclude Military Health System (MHS) beneficiaries. The purpose of this study is to characterize MHS beneficiaries with limb loss and absence and estimate incidence and prevalence.

Material And Methods: We conducted a retrospective cohort study using data from the MHS Information Platform. Descriptive statistics were used to characterize the study population, including demographics, level of limb loss and absence, and etiology. Bivariate analyses between demographic characteristics and level of limb loss were conducted using analysis of variance and chi-square tests. The sample includes MHS beneficiaries diagnosed with limb loss or absence from 2005 to 2023. The study was determined exempt human subjects research by the Uniformed Services University of the Health Sciences Institutional Review Board.

Results: The cohort (118,587) was 64.6% male and 35.4% female, with mean age 58 years (SD = 23.4). Racial distribution included 49.8% White, 6.4% Black, and approximately 42.1% other or unknown. Service branches were Army (41.0%), Air Force (26.7%), Navy (19.7%), Marine Corps (7.0%), other (3.9%), Coast Guard (1.7%), and Space Force (0%). The majority were retired (46.2%) or other (32.0%), with a smaller portion active duty (12.0%) and dependents (9.9%). Levels of limb loss were 72% lower limb, 26.1% upper limb, and 2% unspecified. Causes included acquired absence (53.8%), traumatic amputation (34%), and congenital absence (12.1%). Bivariate analysis showed significant associations between demographics and limb loss levels (P = .000). Incidence (z = -2.43, P = .015) and prevalence (z = -13.69, P = .000) rates declined over 19 and 8 years, respectively.

Conclusion: This study highlights demographic characteristics, causes, and declining rates of limb loss and absence among MHS beneficiaries, providing a foundation for future research and informing clinical practices and policies to enhance care and resource allocation.

Download full-text PDF

Source
http://dx.doi.org/10.1093/milmed/usaf386DOI Listing

Publication Analysis

Top Keywords

limb loss
36
loss absence
24
mhs beneficiaries
16
limb
10
loss
9
absence
8
military health
8
health system
8
level limb
8
demographic characteristics
8

Similar Publications

Background: Repair strategies for pediatric vascular injuries must consider vascular growth and intervention durability. Endovascular interventions are increasingly utilized in pediatrics, particularly in unstable patients or for injuries in surgically morbid regions. This study describes a single-center experience with endovascular stenting in adolescent pediatric trauma.

View Article and Find Full Text PDF

FPR2 Agonism Attenuates Restenosis by Mitigating Neointimal Hyperplasia via ELOVL6.

FASEB J

September 2025

State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

Restenosis following endovascular intervention in lower extremity arterial disease contributes to significant morbidity and mortality. This study investigates the role of formylpeptide receptor 2 (FPR2) in neointimal hyperplasia and evaluates the therapeutic potential of the selective FPR2 agonist BMS-986235 in mitigating restenosis. FPR2 expression was significantly reduced in the popliteal and anterior tibial arteries of male amputees with restenosis compared to healthy controls.

View Article and Find Full Text PDF

Objective: The role of amputation and myoelectric prosthetic fitting for hand function in traumatic pan-brachial plexus injury (pBPI) continues to evolve. This study evaluated the function and activity performance of patients with traumatic pBPI who underwent amputation and prosthetic fitting with a myoelectric prosthesis (MEP) for hand function.

Methods: A retrospective analysis of adult patients who underwent elective amputation after sustaining a pBPI followed by MEP for hand function was performed.

View Article and Find Full Text PDF

Background And Objectives: Slow and highly variable disease progression in Becker muscular dystrophy (BMD) stresses the need to develop sensitive outcome measures for clinical trials. We evaluated responsiveness of different outcome measures in adult patients with BMD over 3 years and explored if the sensitivity of outcome measures can be increased by selecting on phenotype or genotype.

Methods: Genetically confirmed patients with BMD were recruited via the Dutch Dystrophinopathy Database.

View Article and Find Full Text PDF